Mesothelioma.com Resources for Patients and their Families
Request Free Guide

The MCA Blog

Connecting with others one story at a time Survivor Ribbon

Results for “Mesothelioma”

FDA Approves New Mesothelioma Treatment for the First Time in 15 Years

FDA Approves New Mesothelioma Treatment for the First Time in 15 Years

Malignant mesothelioma is an aggressive disease that is most often diagnosed in the later stages, at stage 3 or stage 4. Late-stage diagnoses limit treatment options for the patient, typically eliminating the possibility of radical surgeries. Multimodal therapy is the most common treatment for mesothelioma cancer, consisting of a combination of surgery, chemotherapy, and/or radiation. The possibility of multimodal therapy or what combination is used depends on a case-by-case basis.

Continue Reading »

EPA’s New Rule Shows Resistance to the Need for an Asbestos Ban

EPA’s New Rule Shows Resistance to the Need for an Asbestos Ban

Asbestos is still not banned in the United States, despite the warnings and concerns of scientists and advisors. Asbestos is known to cause a series of diseases, including malignant mesothelioma, an aggressive cancer. The Environmental Protection Agency (EPA) has put various rules and regulations into place to help protect the public and the environment from the dangers of asbestos, however, their recent rule calls their protections into question.

Continue Reading »

Mesothelioma Survivor Heather Von St. James Reflects on Mother’s Day

Mesothelioma Survivor Heather Von St. James Reflects on Mother’s Day

In true mom fashion, my mother announces, “I’m going to be your mother now…” and dispenses her advice, which is usually right on the money. This was never more true in my life than when I got pregnant with my only child. My pregnancy was easy, but things in my life at the time warranted my mom using that phrase “I’m going to be your mother now” more than once.

Continue Reading »

New Study Identifies Six Factors Associated with Improved Mesothelioma Survival

New Study Identifies Six Factors Associated with Improved Mesothelioma Survival

Improving mesothelioma survival rates has been at the forefront of research for years, as the cancer has long been recognized for its poor prognosis due to a number of factors like difficulties in early detection and aggressive cell types. A recent study from the University of Pittsburgh has discovered six factors that they believe are associated with improved survival among mesothelioma patients and can help drive future research efforts to improve patient life expectancy. Currently, most mesothelioma patients live an average of 12 – 21 months following diagnosis. The team from the University of Pittsburgh set out to understand why patient survival varies so widely to help pinpoint research areas and drive future clinical trials.

Continue Reading »

New Clinical Trial Will Test WT1 Immunotherapy Drug with Nivolumab for Recurrent Mesothelioma

Researchers have found that recurrent rates for mesothelioma can vary widely, with some studies finding recurrence rates after treatment ranging from 10 – 72%. Even patients diagnosed in the earlier stages and who are able to undergo aggressive multimodal treatment have been found to experience recurrence. Because of the rather high likelihood of the cancer recurring, a heavy focus of mesothelioma research is finding optimal second- and third-line treatments for patients who have previously been treated and either experience recurrence or their cancer is unresponsive.

Continue Reading »

Resources for Mesothelioma Patients and Their Families

Mesothelioma Diagnosis Leads to $29 Million Verdict Against Johnson & Johnson

Mesothelioma Diagnosis Leads to $29 Million Verdict | Mesothelioma.com

A California jury reached a $29 million verdict against Johnson & Johnson and Cyprus Mines Corporation, a talc supplier. The jury concluded that the responsible companies must pay Teresa Leavitt over $29 million after she was exposed to asbestos through the long-term use of Johnson & Johnson baby powder. Leavitt claims that the talcum powder is the reason that she has developed mesothelioma, an aggressive cancer caused by asbestos.

Continue Reading »

The 2019 International Symposium on Malignant Mesothelioma Brings Experts and Patients Together

The 2019 International Symposium on Malignant Mesothelioma Brings Experts and Patients Together

From March 25th – 27th, the Mesothelioma Applied Research Foundation will host its annual International Symposium on Malignant Mesothelioma in Bethesda, Maryland. The Meso Foundation has organized the event since 2004 to help bring the mesothelioma community together, offering patients and loved ones insight to the latest treatments and research, facetime with renowned mesothelioma experts, and the opportunity to connect with others facing similar experiences.

Continue Reading »

Two Clinical Trials Show Potential of Opdivo for Recurrent Mesothelioma

Two Clinical Trials Show Potential of Opdivo for Recurrent Mesothelioma

One of the prominent areas of mesothelioma research today is around the development of an effective, tolerable, second-line treatment for recurrent cases. Studies have shown mesothelioma recurrence is highly prevalent, even among patients who are able to undergo aggressive primary therapy, like surgery. Some studies have noted recurrence rates ranging from 10 – 72% of patients.

Continue Reading »

Lucky 13: Celebrating 13 Years of Survivorship

Lucky 13: Celebrating 13 Years of Survivorship | Mesothelioma.com

February 2nd, 2019 will mark 13 years since my life-saving surgery done by the late Dr. David Sugarbaker. 13 years was not even something I thought I could achieve all those years ago when I was told I had just 15 months to live. Over the last 13 years, I have had so much to be thankful and grateful for. All I have to do is look at my daughter, who was just a tiny, serious baby when I was diagnosed, and now she is taller than I am – a fact she is all too happy to point out at every moment possible! 13 years of scanxiety, 13 years of advocacy, and 13 years of living for today.

Continue Reading »

How Dropping DNA into Water May Reveal Mesothelioma

How Dropping DNA into Water May Reveal Mesothelioma

Scientists at the University of Queensland in Australia have been working to find a cancer test that will detect cancer sooner, allowing patients to begin treatment earlier and improve their prognosis. This is particularly influential for rare cancers like malignant mesothelioma that are difficult to detect. Early detection is the best way to improve mesothelioma prognosis, stressing the need to find better diagnostic tools.

Continue Reading »

Next >

Search the MCA Blog:

Mesothelioma Treatment Guide

Free Mesothelioma Treatment Guide

Please fill in the form below to request our FREE Mesothelioma Treatment Guide. It will be sent to you within 24 hours.

Have you or someone you know been diagnosed with mesothelioma?

Get Access To:

Legal Rights Information Guide Free Guide Request Free Guide Free Mesothelioma Guide Free 2019 Mesothelioma Guide